Share

More News


  • 9-November-2021

    English

    COVID-19 pandemic underlines need to strengthen resilience of health systems, says OECD

    COVID‑19 contributed to a 16% increase in the expected number of deaths in 2020 and the first half of 2021 across OECD countries. Life expectancy fell in 24 of 30 countries with comparable data, with drops particularly large in the United States (‑1.6 years) and Spain (‑1.5 years), according to a new OECD report.

    Related Documents
  • 25-October-2021

    English

    Improving Regulatory Delivery in Food Safety - Mitigating Old and New Risks, and Fostering Recovery

    This report describes how regulators around the world adapted to the confusion brought by the COVID-19 crisis to ensure the supply of food while maintaining food safety and security. It brings together examples of regulatory responses at regional, national and international levels. The report also discusses how, despite all the challenges, the pandemic has helped uncover new regulatory tools and foster a culture of flexibility and agility in regulatory systems.
  • 25-June-2021

    English, PDF, 1,729kb

    OECD Work on Health - Brochure

    This new brochure presents the OECD Work on Health, including all recent and forthcoming major publications and databases.

  • 8-June-2021

    English

    Improving mental health care key to COVID-19 pandemic recovery

    The COVID-19 pandemic has led to a sharp increase in mental ill-health issues, especially among the young, unemployed and those facing financial insecurity. Countries should provide adequate support to those affected, while urgently scaling up investment and quality of care to reduce the high social and economic costs of mental ill-health, according to a new OECD report.

    Related Documents
  • 19-May-2021

    English

    Governments should step up their efforts to tackle harmful alcohol consumption

    Investing in policies to reduce harmful alcohol consumption would save millions of lives. The economic benefits of putting them in place would also be much higher than the costs, according to a new OECD report.

    Related Documents
  • 31-March-2021

    English

    Access to COVID-19 vaccines: Global approaches in a global crisis

    Following the extraordinarily rapid development of COVID-19 vaccines, immunisation is underway in many OECD countries. However, demand will continue to outstrip supply for some time and currently, distribution is strongly skewed in favour of high-income countries. This both inequitable and inefficient.

    Related Documents
  • 1-March-2021

    English

    Building and sustaining collaborative platforms in genomics and biobanks for health innovation

    Genomic and biobank collaborative platforms hold significant promise for the development of new discoveries and therapies. This paper explores the complex technical, legal and business challenges arising from genomics and biobanks, and brings together ideas and best practices from major national and international platforms, and from a diverse range of experts. The global sharing of biological samples and genomic data has been critical for accelerating our understanding of the biology and spread of COVID-19, and for the development of vaccines and diagnostics. Although some of the policy challenges in the field are well known, they have been reconfigured by the digitalisation of health innovation combined with the increasing complexity and volume of data, the push for global collaboration, and the growing awareness of ethical, legal, and social implications.
  • 2-September-2020

    English

    OECD Newsletter on Health, Employment, Migration and Social Affairs

    The OECD regularly publishes newsletters featuring the latest publications, analysis and opinion on Health, Employment, Migration and Social Affairs. Find out how to subscribe here.

    Related Documents
  • 13-November-2019

    English

    Pharmaceutical Residues in Freshwater - Hazards and Policy Responses

    This report calls for a better understanding of the effects of pharmaceutical residues in the environment, greater international collaboration and accountability distribution, and policy actions to prevent and remedy emerging concerns. Laboratory and field tests show traces of oral contraceptives causing the feminisation of fish and amphibians, and residues of psychiatric drugs altering fish behaviour. Antimicrobial resistance, linked to the overuse of antibiotics, has rapidly escalated into a global health crisis. Unless adequate measures are taken to manage the risks, pharmaceutical residues will increasingly be released into the environment as ageing populations, advances in healthcare, and intensification of meat and fish production spur the demand for pharmaceuticals worldwide. The report outlines a collective, life-cycle approach to managing pharmaceuticals in the environment. A policy mix of source-directed, use-orientated and end-of-pipe measures, involving several policy sectors, can help to improve health and protect the environment.
  • 6-November-2019

    English

    Safety Assessment of Foods and Feeds Derived from Transgenic Crops, Volume 3 - Common bean, Rice, Cowpea and Apple Compositional Considerations

    This volume compiles the consensus documents developed by the OECD Working Group for the Safety of Novel Foods and Feeds from 2015 to 2019. It deals with the composition of common bean, rice, cowpea and apple, four important crops for agriculture and food consumption worldwide. The science-based information collated here is intended for use during the regulatory assessment of food/feed products derived from modern biotechnology, i.e. issued from transgenic plants. Compositional considerations are provided for each species, including tables detailing the key nutrients, anti-nutrients, possible toxicants, allergens and other metabolites contained in the products. This essential information and solid data can be used in the comparative approach as part of the novel food/feed safety assessment. It should be of value to crop breeders and applicants for commercial uses of novel foods and feeds, to regulators and risk assessors in national authorities, as well as the wider scientific community. More information can be found at BioTrack Online.
  • << < 1 | 2 | 3 | 4 | 5 | 6 > >>